|77.38|| +0.77 / +1.01%|
Medtronic Plc Formerly known as Medtronic, Inc. The Group's principal activities are manufacturing, developing and marketing medical technology and providing device-based medical therapies. It operates in eight segments: Cardiac Rhythm Disease Management (CRDM), Spinal, CardioVascular, Neuromodulation, Diabetes, Surgical Technologies, Physio-Control. It provides lifelong solutions for people with chronic diseases. It also offers therapeutic and diagnostic devices used for the treatment of diabetes, neurological, gastroenterological, urological, and movement disorders, spinal and neurosurgery, neurodegenerative disorders and ear, nose and throat (ENT) surgery. It provides external and manual defibrillators. The Group operates in the United States, Europe, the Asia Pacific and other foreign countries.
|Omar S. Ishrak||Chairman & Chief Executive Officer|
|Gary Lee Ellis||Chief Financial Officer & Executive Vice President|
|Bradley E. Lerman||Secretary, Senior Vice President & General Counsel|